In vitro-in vivo correlation: Perspectives on model development

International Journal of Pharmaceutics

Volumn 418, Issue 1, 2011, Pages 142-148

  Lu, Ying ^a   Kim, Sungwon ^a   Park, Kinam ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

Biopharmaceutics; In vitro in vivo correlation; Modeling; Oral dosage form

Indexed keywords

ARTICLE; CORRELATION ANALYSIS; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO IN VIVO CORRELATION; MATHEMATICAL MODEL; PARTITION COEFFICIENT; PH; PRIORITY JOURNAL;

EID: 80052846753     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.01.010     Document Type: Review

References (32)

1. L.C. Amann, M.J. Gandal, R. Lin, Y.L. Liang, and S.J. Siegel In vitro-in vivo correlations of scalable plga-risperidone implants for the treatment of schizophrenia Pharm. Res. 27 2010 1730 1737
2. G. Balan, P. Timmins, D.S. Greene, and P.H. Marathe In vitro-in vivo correlation models for metformin after administration of modified release oral dosage forms to healthy human volunteers J. Pharm. Sci. 90 2001 1176 1185
3. S. Bigora, D. Piscitelli, and J. Dowell Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations D. Young, J.G. Devane, J. Butler, Advances in Experimental Medicine and Biology 1997 Plenum Press New York 207 215
4. P. Buch, P. Holm, J.Q. Thomassen, D. Scherer, R. Branscheid, U. Kolb, and P. Langguth IVIVC for fenofibrate immediate release tablets using solubility and permeability as in vitro predictors for pharmacokinetics J. Pharm. Sci. 99 2010 4427 4436
5. P. Buchwald Direct, differential equation based in vitro-in vitro correlation method J. Pharm. Pharmacol. 55 2003 495 504
6. J.A. Carlson, H.J. Mann, and D.M. Canafax Effect of pH on disintegration and dissolution of ketoconazole tablets Am. J. Hosp. Pharm. 40 1983 1334 1336 (Pubitemid 13026305)
7. A. Dokoumetzidis, V. Papadopoulou, and P. Macheras Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function Pharm. Res. 23 2006 256 261 (Pubitemid 43237856)
8. J.B. Dressman, G.L. Amidon, and D. Fleisher Absorption potential: estimating the fraction absorbed for orally administered compounds J. Pharm. Sci. 74 1985 588 589
9. A. Dunne Approaches to developing in vitro-in vivo correlation models D.M. Chilukuri, G. Sunkara, D. Young, Pharmaceutical Product Development 2007 Informa Healthcare USA New York 47 70
10. N.D. Eddington, P. Marroum, R. Uppoor, A. Hussain, and L. Augsburger Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation Pharm. Res. 15 1998 466 473 (Pubitemid 28175130)
11. L.J. Edwards The dissolution and diffusion of aspirin in aqueous media Trans. Faraday Soc. 47 1951 1191 1210
12. L. Finkelstein, and E.R. Carson Mathematical Modelling of Dynamic Biological Systems second ed. 1985 John Wiley & Sons New York
13. A. Finkelstein, D. McClean, and S. Kar Local drug delivery via coronary stent with programmable release pharmacokinetics Circulation 107 2003 777 784 (Pubitemid 36222609)
14. C. Hansch, and T. Fugita Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure J. Am. Chem. Soc. 86 1964 1616 1626
15. K.C. Johnson, and A.C. Swindell Guidance in the setting of drug particle size specification to minimize variability in absorption Pharm. Res. 13 1996 1795 1798 (Pubitemid 27034109)
16. S.D. Kramer Absorption prediction from physicochemical parameters Pharm. Sci. Technol. Today 2 1999 373 380 (Pubitemid 29424131)
17. M. Kutner, C. Nachtsheim, J. Neter, and W. Li Applied Linear Statistical Models fifth ed. 2004 McGraw-Hill New York
18. F. Langenbucher Handling of computational in vitro/in vivo correlation problems by microsoft excel II. Distribution of functions and moments Eur. J. Pharm. Biopharm. 55 2003 77 84 (Pubitemid 36120498)
19. S.F. Li, H.D. He, L.J. Parthiban, H.Q. Yin, and A.T.M. Serajuddin IVIVC considerations in the development of immediate-release oral dosage form J. Pharm. Sci. 94 2005 1396 1417 (Pubitemid 41168672)
20. A.M. Lincoff, J.G. Furst, S.G. Ellis, R.J. Tuch, and E.J. Topol Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model J. Am. Coll. Cardiol. 29 1997 808 816 (Pubitemid 27128255)
21. J. Mendell-Harary, J. Dowell, and S. Bigora Nonlinear in vitro-in vivo correlations D. Young, J.G. Devane, J. Butler, Advances in experimental medicine and biology 1997 Plenum Press New York 199 206 (Pubitemid 27347205)
22. N.B. Modi In vitro-in vivo correlation D.M. Chilukuri, G. Sunkara, S.G. Young, Pharmaceutical Product Development 2007 Informa Healthcare USA New York 107 123
23. E. Nelson Solution rate of theophylline salts and effects from oral administration J. Am. Pharm. Assoc. Sci. Ed. 46 1957 608 614
24. L. Ochoa, M. Igartua, R.M. Hernandez, M.A. Solinis, A.R. Gascon, and J.L. Pedraz In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: level A in vitro-in vivo correlation Eur. J. Pharm. Biopharm. 75 2010 232 237
25. J.E. Polli, J.R. Crison, and G.L. Amidon Novel approach to the analysis of in vitro-in vivo relationships J. Pharm. Sci. 85 1996 753 760 (Pubitemid 26234682)
26. A.T.M. Serajuddin, and C.I. Jarowski Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts J. Pharm. Sci. 1985 82
27. J.A. Shabbits, G.N.C. Chiu, and L.D. Mayer Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems J. Control. Release 84 2002 161 170 (Pubitemid 35435319)
28. P.A. Shore, B.B. Brodie, and C.A.M. Hogben The gastric secretion of drugs: a pH partition hypothesis J. Pharmacol. Exp. Ther. 119 1957 361 369
29. N. Sirisuth, L.L. Augsburger, and N.D. Eddington Development and validation of a non-linear IVIVC model for a diltiazem extended release formulation Biopharm. Drug Dispos. 23 2002 1 8 (Pubitemid 34256937)
30. The Food and Drug Administration, U.S.; 1997. Extended Release Solid Dosage Forms: Development, Evaluation and Application of In vitro/In vivo correlations. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070239.pdf.
31. The Food and Drug Administration, U.S.; 2005. FDA Guidance for Industry - Waiver on In vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms based on a Biopharmaceutics Classification Systems. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf.
32. D. Winne Shift of pH-absorption curves J. Pharmacokinet. Biopharm. 5 1976 53 94